Peiwei Wang

110 Ganhe Rd
Shanghai, 200437, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated m6A RNA modification in NETs-induced endothelial activation.

Ginsenoside Rb1 mitigates atherosclerosis in part through modulating FTO-mediated m6A RNA modification in NETs-induced endothelial activation.

Journal: Frontiers in pharmacology

Published: May 19, 2025

Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II.

Cinnamic acid alleviates hypertensive left ventricular hypertrophy by antagonizing the vasopressor activity and the pro-cardiac hypertrophic signaling of angiotensin II.

Journal: Frontiers in pharmacology

Published: January 06, 2025

Baicalin mitigates hyperglycemia-linked intestinal epithelial barrier impairment in part by inhibiting the formation of neutrophil extracellular traps.

Baicalin mitigates hyperglycemia-linked intestinal epithelial barrier impairment in part by inhibiting the formation of neutrophil extracellular traps.

Journal: Frontiers in immunology

Published: December 25, 2024

Ginsenoside Rb1 mitigates acute catecholamine surge-induced myocardial injuries in part by suppressing STING-mediated macrophage activation.

Ginsenoside Rb1 mitigates acute catecholamine surge-induced myocardial injuries in part by suppressing STING-mediated macrophage activation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 17, 2024

Hyperoside protects against oxidative stress-mediated photoreceptor degeneration: therapeutic potentials for photoreceptor degenerative diseases.

Hyperoside protects against oxidative stress-mediated photoreceptor degeneration: therapeutic potentials for photoreceptor degenerative diseases.

Journal: Journal of translational medicine

Published: May 25, 2023

Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes.

Cinnamic acid mitigates left ventricular hypertrophy and heart failure in part through modulating FTO-dependent N6-methyladenosine RNA modification in cardiomyocytes.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 25, 2023

Circulating MicroRNA-505 May Serve as a Prognostic Biomarker for Hypertension-Associated Endothelial Dysfunction and Inflammation.

Circulating MicroRNA-505 May Serve as a Prognostic Biomarker for Hypertension-Associated Endothelial Dysfunction and Inflammation.

Journal: Frontiers in cardiovascular medicine

Published: December 13, 2021

Dual Activity of Ginsenoside Rb1 in Hypertrophic Cardiomyocytes and Activated Macrophages: Implications for the Therapeutic Intervention of Cardiac Hypertrophy.

Dual Activity of Ginsenoside Rb1 in Hypertrophic Cardiomyocytes and Activated Macrophages: Implications for the Therapeutic Intervention of Cardiac Hypertrophy.

Journal: Journal of inflammation research

Published: March 12, 2021

KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression.

KLF2 regulates neutrophil activation and thrombosis in cardiac hypertrophy and heart failure progression.

Journal: The Journal of clinical investigation

Published: December 23, 2020

Candesartan attenuates hypertension-associated pathophysiological alterations in the gut.

Candesartan attenuates hypertension-associated pathophysiological alterations in the gut.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 02, 2019

Targeted regulation of Rell2 by microRNA-18a is implicated in the anti-metastatic effect of polyphyllin VI in breast cancer cells.

Targeted regulation of Rell2 by microRNA-18a is implicated in the anti-metastatic effect of polyphyllin VI in breast cancer cells.

Journal: European journal of pharmacology

Published: August 10, 2018

Direct repression of IGF2 is implicated in the anti-angiogenic function of microRNA-210 in human retinal endothelial cells.

Direct repression of IGF2 is implicated in the anti-angiogenic function of microRNA-210 in human retinal endothelial cells.

Journal: Angiogenesis

Published: June 08, 2017

Showing 1-12 of 23

Last Updated: 09/26/2026